- glossary ON | OFF
- |
-
text zoom - |
- e-mail page
- |
- print page
Focus on HER2
Slide Deck
View the HER2 slide deck
“Patients with multiple copies of the [HER2] gene in DNA from their tumors had a shorter time to relapse as well as a shorter overall survival indicating that gene amplification was prognostic for disease behavior in these individuals.”— Slamon D et al, Science, 19891
Dysregulation of HER2 signaling drives the development of multiple tumor types. This section of ResearchHERPathways.com explores the biology of HER2, the methods by which it is detected, its value as a prognostic factor, and its role in breast and ovarian cancer. Click on the links below to learn more.
In This Section
